Vunakizumab Combined With Recaticimab in Subjects With Moderate to Severe Plaque Psoriasis and Dyslipidemia
Clinical trial NCT07373847 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07373847
- Sponsor
- Xiangya Hospital of Central South University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-20
- Primary completion
- 2027-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.